Dr. Pedro Covas, MD

Dr. Covas practices at West Kendall Baptist Hospital in Miami, Florida, part of Baptist Health South Florida.

Dr. Covas' NPI, 1285167239, was assigned on April 6, 2017. Dr. Covas graduated from Lewis Katz School of Medicine in 2017. Dr. Covas' District of Columbia license number on file is MD048014.

Dr. Covas' primary practice is West Kendall Baptist Hospital, at 9555 Sw 162 Ave, Miami, FL 33196 in Miami-Dade County. The practice phone is (786) 467-2000.

Dr. Covas' primary practice is West Kendall Baptist Hospital in Miami, Florida, part of Baptist Health South Florida. Dr. Covas is also affiliated with Sylvester Comprehensive Cancer Center. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Covas to 1 more hospital, 5 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Covas practices, 6 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Covas' primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Covas is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Covas' licenses on file in 3 states: District of Columbia, Florida and Virginia.

CMS data shows 32 Medicare services from Dr. Covas across 1 procedure code in 2024, for 90 Medicare patients. Medicare paid $1,761 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 90 Medicare patients who saw Dr. Covas in 2024. The largest group is 65 to 74, with 39 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 41% are also on Medicaid. Their average risk score is 1.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Covas' median patient age at 70, with 53% women.

In 2024, Dr. Covas wrote 58 Medicare Part D claims for 30 patients. 79% of them were for generic drugs. CMS names the drug for 25 of them, across 2 drugs with 11 or more claims each, at $770 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Covas for performance year 2024. Dr. Covas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Covas as offering telehealth.

Dmand AI links 6 papers to Dr. Covas, published from 2020 to 2023. 2021 was the busiest year, with 3. Dr. Covas' most frequent co-authors are Andrew Dongyul Choi, MD, Cynthia M. Tracy, MD and Andrew J. Bradley, MD.

CMS Open Payments shows 51 general payments to Dr. Covas from 19 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 94% of the total. Abbott Laboratories paid the most, $685.

Dr. Covas graduated from Lewis Katz School of Medicine in 2017.

Dr. Covas is in network with 11 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.